Home/Pipeline/ONO-4538 combinations

ONO-4538 combinations

Solid tumors

Phase 2Active

Key Facts

Indication

Solid tumors

Phase

Phase 2

Status

Active

Company

Ono Pharmaceutical

About Ono Pharmaceutical

Ono Pharmaceutical Co., Ltd. is one of Japan's oldest and most established pharmaceutical companies with over 300 years of history. The company has evolved from traditional medicine to become a leader in oncology, particularly through its co-development of Opdivo with Bristol Myers Squibb, which has become one of the world's leading cancer immunotherapies. Ono maintains a strong focus on research and development with particular expertise in immunology, oncology, and CNS disorders, while expanding its presence in international markets.

View full company profile

Therapeutic Areas

Oncology Immunology Dermatology CNS Autoimmune

Other Solid tumors Drugs

Drug	Company	Phase	Status
GSK4362676	GSK plc	Phase 1	Active
ABBV-154	AbbVie	Phase 1	Active
TAK-981	Takeda Pharmaceutical	Phase 1/2	Active
TAK-676	Takeda Pharmaceutical	Phase 1	Active
TAK-573	Takeda Pharmaceutical	Phase 1	Active
TAK-164	Takeda Pharmaceutical	Phase 1	Active
SHR-1316	Jiangsu Hengrui Medicine	Phase 1/2	Active
BAY 2927088	Bayer	Phase 1	Active
ASP1929	Astellas Pharma	Phase 2	Active
IBI188	Innovent Biologics	Phase 1	Active
Bispecific Antibody	Akeso	Phase 1/2	Active
CSPC-DM02	CSPC Pharmaceutical Group Limited	Phase 2	Active